GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Jack West describes his evolving perspective on the yield of testing for molecular markers, which is leading him to become more optimistic about testing a broader range of people with NSCLC.

Direct download: GRACEcastUC-012_Lung-Video_More_You_Seek_More_You_Find.m4v
Category:Lung-Cancer-Video -- posted at: 12:33pm PDT

Dr. Hy Muss reviews potential benefits of treatment for advanced, metastatic breast cancer, as well as the value of functional assessment of patients to predict treatment tolerability.

Direct download: GRACEcast-133_Breast-Video_Functional_Assessment_of_Pts_4.m4v
Category:Breast-Cancer-Video -- posted at: 4:25pm PDT

Dr. Hy Muss reviews potential benefits of treatment for advanced, metastatic breast cancer, as well as the value of functional assessment of patients to predict treatment tolerability.

Direct download: GRACEcast-133_Breast-Audio_Functional_Assessment_of_Pts_4.mp3
Category:Breast-Cancer-Audio -- posted at: 4:25pm PDT

Dr. Jack West wishes the cancer community a happy holiday season from GRACE.

Direct download: GRACEcastUC-011_CA-101-Video_Happy_Holidays_Dr_West_GRACE.m4v
Category:Cancer-101-Video -- posted at: 5:16pm PDT

Dr. Jack West describes a potentially efficient way to improve delivery of increasingly specialized care to broad geographic areas by collaboration of healthcare network teams using telemedicine solutions currently available.


Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, discusses leading surgery options for breast cancer and how we estimate the value of post-operative therapy.


Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, discusses leading surgery options for breast cancer and how we estimate the value of post-operative therapy.


Dr. Jack West discusses the pros and cons of repeat biopsies of tumors in the setting of "acquired resistance" to targeted therapies, with a specific consideration of whether this should be considered a standard of care.

Direct download: GRACEcastUC-009_CA-101-Video_Repeat_Biopsies_with_Progression.m4v
Category:Cancer-101-Video -- posted at: 8:00am PDT

Dr. Jack West reviews the limitations of artificial intelligence applied to clinical decision-making in complex cases in oncology, and why Dr. Watson won't necessarily become the perfect oncologist.


Dr. Dara Aisner, Pathologist at the University of Colorado, describes emerging technological changes that will advance how molecular marker testing is done, to make it faster and more complete over time.

Direct download: GRACEcast-131_CA-101-Audio_Future_of_Molecular_Pathology_3.mp3
Category:Cancer-101-Audio -- posted at: 8:00am PDT

Dr. Dara Aisner, Pathologist at the University of Colorado, describes emerging technological changes that will advance how molecular marker testing is done, to make it faster and more complete over time.

Direct download: GRACEcast-131_CA-101-Video_Future_of_Molecular_Pathology_3.m4v
Category:Cancer-101-Video -- posted at: 12:00am PDT

Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, discusses considerations around prevention, screening, and treatment considerations for older women with breast cancer.


Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, discusses considerations around prevention, screening, and treatment considerations for older women with breast cancer.


Dr. Jack West reviews what situations would make a "local" treatment like radiation appropriate in a situation where a patient has known advanced/metastatic lung cancer. 

Direct download: GRACEcastUC-006_Lung-Video_Which_Patients_for_Local_Therapy.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Dr. Jack West reviews a case that illustrates the potential option of systemic therapy for brain metastases before initiating whole brain radiation.

Direct download: GRACEcastUC-007_Rad-Video_Alternative_to_Brain_Radiation.m4v
Category:Radiation-Video -- posted at: 8:00am PDT

Dr. Dara Aisner, Pathologist at the University of Colorado, reviews several practical challenges about having enough tissue for molecular testing, as well as the accuracy of the tests in different labs.

Direct download: GRACEcast-129_CA-101-Audio_Molecular_Pathology_Testing_2.mp3
Category:Cancer-101-Audio -- posted at: 8:00am PDT

Dr. Dara Aisner, Pathologist at the University of Colorado, reviews several practical challenges about having enough tissue for molecular testing, as well as the accuracy of the tests in different labs.

Direct download: GRACEcast-129_CA-101-Video_Molecular_Pathology_Testing_2.m4v
Category:Cancer-101-Video -- posted at: 8:00am PDT

Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, reviews the demographics of breast cancer and the relevance of age in management issues.

Direct download: GRACEcast-128_Breast-Video_Muss_on_Eldery_Breast_Cancer.m4v
Category:Breast-Cancer-Video -- posted at: 7:38pm PDT

Dr. Hy Muss, expert in breast cancer and geriatric oncology at the University of North Carolina at Chapel Hill, reviews the demographics of breast cancer and the relevance of age in management issues.

Direct download: GRACEcast-128_Breast-Audio_Muss_on_Eldery_Breast_Cancer.mp3
Category:Breast-Cancer-Audio -- posted at: 7:37pm PDT

Dr. Dara Aisner, Pathologist at the University of Colorado, defines the field of pathology and molecular marker testing for cancer.

Direct download: GRACEcast-127_CA-101-Video_Aisner_on_Molecular_Pathology.m4v
Category:Cancer-101-Video -- posted at: 9:20pm PDT

Dr. Dara Aisner, Pathologist at the University of Colorado, defines the field of pathology and molecular marker testing for cancer.

Direct download: GRACEcast-127_CA-101-Audio_Aisner_on_Molecular_Pathology.mp3
Category:Cancer-101-Audio -- posted at: 9:19pm PDT

Dr. H. Jack West reviews the TOPICAL study of Tarceva vs. placebo for marginal and poor PS patients with advanced NSCLC, which showed a clearly superior outcome with Tarceva in patients who developed a rash vs. those who don't.

Direct download: GRACEcastUC-005_Lung-Video_Rash_a_Factor_with_EGFR.m4v
Category:Lung-Cancer-Video -- posted at: 6:18pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews the rationale and feasibility of using focal radiation in the setting of metastatic lung cancer.

Direct download: GRACEcast-126_Rad-Video_Refining_Radiation_Therapy_6.m4v
Category:Radiation-Video -- posted at: 4:48pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews the rationale and feasibility of using focal radiation in the setting of metastatic lung cancer.

Direct download: GRACEcast-126_Rad-Audio_Refining_Radiation_Therapy_6.mp3
Category:Radiation-Audio -- posted at: 4:47pm PDT

Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  reviews the rationale for giving chemotherapy to patients with NSCLC even when it appears that the cancer is limited to the chest.

Direct download: GRACEcastUC-004_Lung-Video_Why_Chemptherapy_for_Most.m4v
Category:Lung-Cancer-Video -- posted at: 3:22pm PDT

Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  discusses recent developments around pricing and value for Zaltrap (ziv-aflibercept) triggered by a New York Times op-ed piece by MSKCC physicians.


Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  reviews the general principles of treating locally advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcastUC-002_Lung-Video_How_Should_We_Treat_NSCLC.m4v
Category:Lung-Cancer-Video -- posted at: 12:57pm PDT

Dr. H. Jack West describes the new format of presenting cancer information in brief, more casual video-based format.

Direct download: GRACEcastUC-001_CA-101-Video_Intro_to_GRACEcasts_Uncut.mp4
Category:Cancer-101-Video -- posted at: 10:32pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes new technologies that are improving the accuracy and safety of radiation for stage non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-125_Rad-Video_Refining_Radiation_Therapy_5.m4v
Category:Radiation-Video -- posted at: 9:46pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes new technologies that are improving the accuracy and safety of radiation for stage non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-125_Rad-Audio_Refining_Radiation_Therapy_5.mp3
Category:Radiation-Audio -- posted at: 9:45pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, covers the benefits and limitations of stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-124_Rad-Video_Refining_Radiation_Therapy_4.m4v
Category:Radiation-Video -- posted at: 10:44am PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, covers the benefits and limitations of stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-124_Rad-Audio_Refining_Radiation_Therapy_4.mp3
Category:Radiation-Audio -- posted at: 10:43am PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews recent successful experiences with stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer and reviews several open questions about this strategy.

Direct download: GRACEcast-123_Rad-Audio_Refining_Radiation_Therapy_3.mp3
Category:Radiation-Audio -- posted at: 8:00am PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, reviews recent successful experiences with stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer and reviews several open questions about this strategy.

Direct download: GRACEcast-123_Rad-Video_Refining_Radiation_Therapy_3.m4v
Category:Radiation-Video -- posted at: 8:00am PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes the ways to modulate the efficacy of radiation and explains why stereotactic body radiation therapy (SBRT) may be particularly effective for early lung cancer.

Direct download: GRACEcast-122_Rad-Audio_Refining_Radiation_Therapy_2.mp3
Category:Radiation-Audio -- posted at: 8:00am PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, describes the ways to modulate the efficacy of radiation and explains why stereotactic body radiation therapy (SBRT) may be particularly effective for early lung cancer.

Direct download: GRACEcast-122_Rad-Video_Refining_Radiation_Therapy_2.m4v
Category:Radiation-Video -- posted at: 8:00am PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, provides a historical perspective of radiation therapy as it transitions to a more targeted treatment approach.

Direct download: GRACEcast-121_Rad-Video_Refining_Radiation_Therapy.m4v
Category:Radiation-Video -- posted at: 3:42pm PDT

Dr. Vivek Mehta, Radiation Oncologist at Swedish Cancer Institute in Seattle, WA, provides a historical perspective of radiation therapy as it transitions to a more targeted treatment approach.

Direct download: GRACEcast-121_Rad-Audio_Refining_Radiation_Therapy.mp3
Category:Radiation-Audio -- posted at: 3:41pm PDT

Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by EGFR inhibitors or chest radiation.

Direct download: GRACEcast-120_Lung-Video_Pulmonary_Complications_of_LC_2.m4v
Category:Lung-Cancer-Video -- posted at: 7:15pm PDT

Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by EGFR inhibitors or chest radiation.

Direct download: GRACEcast-120_Lung-Audio_Pulmonary_Complications_of_LC_2.mp3
Category:Lung-Cancer-Audio -- posted at: 7:15pm PDT

Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by chemotherapy commonly used for treating lung cancer.

Direct download: GRACEcast-119_Lung-Video_Pulmonary_Complications_of_LC.m4v
Category:Lung-Cancer-Video -- posted at: 7:33pm PDT

Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by chemotherapy commonly used for treating lung cancer.

Direct download: GRACEcast-119_Lung-Audio_Pulmonary_Complications_of_LC.mp3
Category:Lung-Cancer-Audio -- posted at: 7:33pm PDT

Drs. Mark Socinski from Univ. of Pittsburgh and Joel Neal from Stanford Cancer Center answer questions about topics covered in the summary of lung cancer highlights from ASCO 2012.

Direct download: GRACEcast-118_Lung-Video_ASCO_2012_Q_and_A_10.m4v
Category:Lung-Cancer-Video -- posted at: 12:32pm PDT

Drs. Mark Socinski from Univ. of Pittsburgh and Joel Neal from Stanford Cancer Center answer questions about topics covered in the summary of lung cancer highlights from ASCO 2012.

Direct download: GRACEcast-118_Lung-Audio_ASCO_2012_Q_and_A_10.mp3
Category:Lung-Cancer-Audio -- posted at: 12:30pm PDT

Dr. Joel Neal presents interesting early data demonstrating that squamous NSCLC often features identifiable molecular markers that can potentially be targeted by novel therapies.

Direct download: GRACEcast-117_Lung-Audio_ASCO_2012_Neal_9.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PDT

Dr. Joel Neal presents interesting early data demonstrating that squamous NSCLC often features identifiable molecular markers that can potentially be targeted by novel therapies.

Direct download: GRACEcast-117_Lung-Video_ASCO_2012_Neal_9.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell lung cancer. 

Direct download: GRACEcast-116_Lung-Video_ASCO_2012_Neal_8.m4v
Category:Lung-Cancer-Video -- posted at: 4:11pm PDT

Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell lung cancer. 

Direct download: GRACEcast-116_Lung-Audio_ASCO_2012_Neal_8.mp3
Category:Lung-Cancer-Audio -- posted at: 4:11pm PDT

Dr. Joel Neal covers results with afatinib, an irreversible "pan-HER inhibitor", compared with standard chemo for patients with advanced NSCLC and an EGFR mutation.

Direct download: GRACEcast-115_Lung-Video_ASCO_2012_Neal_7.m4v
Category:Lung-Cancer-Video -- posted at: 12:29am PDT

Dr. Joel Neal covers results with afatinib, an irreversible "pan-HER inhibitor", compared with standard chemo for patients with advanced NSCLC and an EGFR mutation.

Direct download: GRACEcast-115_Lung-Audio_ASCO_2012_Neal_7.mp3
Category:Lung-Cancer-Audio -- posted at: 12:29am PDT

Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhibitor, in KRAS mutatino-positive patients with advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-114_Lung-Video_ASCO_2012_Neal_6.m4v
Category:Lung-Cancer-Video -- posted at: 8:57pm PDT

Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhibitor, in KRAS mutatino-positive patients with advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-114_Lung-Audio_ASCO_2012_Neal_6.mp3
Category:Lung-Cancer-Audio -- posted at: 8:56pm PDT

Dr. Joel Neal describes the very encouraging data on anti-PD-1 immunotherapy with BMS-936558/MDX-1106 in patients with advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-113_Lung-Video_ASCO_2012_Neal_5.m4v
Category:Lung-Cancer-Video -- posted at: 5:02pm PDT

Dr. Joel Neal describes the very encouraging data on anti-PD-1 immunotherapy with BMS-936558/MDX-1106 in patients with advanced non-small cell lung cancer (NSCLC).

Direct download: GRACEcast-113_Lung-Audio_ASCO_2012_Neal_5.mp3
Category:Lung-Cancer-Audio -- posted at: 5:01pm PDT

Dr. Mark Socinski reviews key results in small cell lung cancer (SCLC) from ASCO 2012, including the SWOG 0802 trial of topotecan +/- VEGF inhibitor aflibercept and a Japanese randomized trial of cisplatin/amrubicin vs. cisplatin/irinotecan.

Direct download: GRACEcast-112_Lung-Video_ASCO_2012_Socinski_4.m4v
Category:Lung-Cancer-Video -- posted at: 6:01pm PDT

Dr. Mark Socinski reviews key results in small cell lung cancer (SCLC) from ASCO 2012, including the SWOG 0802 trial of topotecan +/- VEGF inhibitor aflibercept and a Japanese randomized trial of cisplatin/amrubicin vs. cisplatin/irinotecan.

Direct download: GRACEcast-112_Lung-Audio_ASCO_2012_Socinski_4.mp3
Category:Lung-Cancer-Audio -- posted at: 6:00pm PDT

Dr. Mark Socinski from University of Pittsburgh summarizes and critiques the TAILOR trial of Taxotere (docetaxel) vs. Tarceva (erlotinib) in EGFR wild type advanced NSCLC.

Direct download: GRACEcast-111_Lung-Video_ASCO_2012_Socinski_3.m4v
Category:Lung-Cancer-Video -- posted at: 8:46pm PDT

Dr. Mark Socinski from University of Pittsburgh summarizes and critiques the TAILOR trial of Taxotere (docetaxel) vs. Tarceva (erlotinib) in EGFR wild type advanced NSCLC.

Direct download: GRACEcast-111_Lung-Audio_ASCO_2012_Socinski_3.mp3
Category:Lung-Cancer-Audio -- posted at: 8:45pm PDT

Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.

Direct download: GRACEcast-110_Lung-Video_ASCO_2012_Socinski_2.m4v
Category:Lung-Cancer-Video -- posted at: 12:44am PDT

Dr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.

Direct download: GRACEcast-110_Lung-Audio_ASCO_2012_Socinski_2.mp3
Category:Lung-Cancer-Audio -- posted at: 12:43am PDT

Dr. Mark Socinski from the University of Pittsburgh reviews the survival benefit and implications from the PARAMOUNT maintenance therapy trial of Alimta (pemetrexed) in advanced NSCLC.

Direct download: GRACEcast-109_Lung-Video_ASCO_2012_Socinski_1.m4v
Category:Lung-Cancer-Video -- posted at: 3:14pm PDT

Dr. Mark Socinski from the University of Pittsburgh reviews the survival benefit and implications from the PARAMOUNT maintenance therapy trial of Alimta (pemetrexed) in advanced NSCLC.

Direct download: GRACEcast-109_Lung-Audio_ASCO_2012_Socinski_1.mp3
Category:Lung-Cancer-Audio -- posted at: 3:13pm PDT

Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews the challenges of depression and fatigue related to cancer, and treatment approaches for these issues.


Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews the challenges of depression and fatigue related to cancer, and treatment approaches for these issues.


Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews nausea in the context of cancer, as well as the range of treatment options to manage it.

Direct download: GRACEcast-107_CA-Rx-Video_Harman_on_Cancer_Nausea.m4v
Category:Treatments-and-Support-Video -- posted at: 1:50pm PDT

Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews nausea in the context of cancer, as well as the range of treatment options to manage it.

Direct download: GRACEcast-107_CA-Rx-Audio_Harman_on_Cancer_Nausea.mp3
Category:Treatments-and-Support-Audio -- posted at: 1:49pm PDT

Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews the main types of pain, the range of treatment options for it, and myths and realities of treating patients with opioids for pain management.

Direct download: GRACEcast-106_CA-Rx-Video_Harman_on_Managing_Pain.m4v
Category:Treatments-and-Support-Video -- posted at: 12:38am PDT

Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, reviews the main types of pain, the range of treatment options for it, and myths and realities of treating patients with opioids for pain management.

Direct download: GRACEcast-106_CA-Rx-Audio_Harman_on_Managing_Pain.mp3
Category:Treatments-and-Support-Audio -- posted at: 12:37am PDT

Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, introduces the concept and goals of palliative care, particularly with a focus on oncology.


Dr. Stephanie Harman, Director of Palliative Care at Stanford University Medical Center, introduces the concept and goals of palliative care, particularly with a focus on oncology.


Drs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immune-based treatments for lung cancer.

Direct download: GRACEcast-104_Lung-Video_Immunotherapies_Q_and_A.m4v
Category:Lung-Cancer-Video -- posted at: 1:36pm PDT

Drs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immune-based treatments for lung cancer.

Direct download: GRACEcast-104_Lung-Audio_Immunotherapies_Q_and_A.mp3
Category:Lung-Cancer-Audio -- posted at: 1:35pm PDT

Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.

Direct download: GRACEcast-103_Lung-Video_Brahmer_on_Immunotherapies.m4v
Category:Lung-Cancer-Video -- posted at: 10:37am PDT

Dr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.

Direct download: GRACEcast-103_Lung-Audio_Brahmer_on_Immunotherapies.mp3
Category:Lung-Cancer-Audio -- posted at: 10:36am PDT

Dr. Ramaswamy Govindan provides a summary of the science behind several promising immunotherapies for lung cancer and the clinical trials that could lead to them being integrated into our treatment plans.

Direct download: GRACEcast-102_Lung-Video_Govindan_on_Immunotherapies.m4v
Category:Lung-Cancer-Video -- posted at: 11:59pm PDT

Dr. Ramaswamy Govindan provides a summary of the science behind several promising immunotherapies for lung cancer and the clinical trials that could lead to them being integrated into our treatment plans.

Direct download: GRACEcast-102_Lung-Audio_Govindan_on_Immunotherapies.mp3
Category:Lung-Cancer-Audio -- posted at: 11:58pm PDT

Dr. Glen Goss, University of Ottawa and NCI-Canada Lung Cancer Committee chair, discusses the potential and limitations of integrating molecular marker studies in advanced non-small cell lung cancer patients across a health care system.

Direct download: GRACEcast-101_Lung-Audio_MMiLC_Panel_Discussion_pt6.mp3
Category:Lung-Cancer-Audio -- posted at: 11:00pm PDT

Dr. Glen Goss, University of Ottawa and NCI-Canada Lung Cancer Committee chair, discusses the potential and limitations of integrating molecular marker studies in advanced non-small cell lung cancer patients across a health care system.

Direct download: GRACEcast-101_Lung-Video_MMiLC_Panel_Discussion_pt6.m4v
Category:Lung-Cancer-Video -- posted at: 10:59pm PDT

Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.

Direct download: GRACEcast-100_Lung-Audio_MMiLC_Panel_Discussion_pt5.mp3
Category:Lung-Cancer-Audio -- posted at: 3:22pm PDT

Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.

Direct download: GRACEcast-100_Lung-Video_MMiLC_Panel_Discussion_pt5.m4v
Category:Lung-Cancer-Video -- posted at: 3:21pm PDT

Panel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients.

Direct download: GRACEcast-099_Lung-Audio_MMiLC_Panel_Discussion_pt4.mp3
Category:Lung-Cancer-Audio -- posted at: 4:52pm PDT

Panel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients.

Direct download: GRACEcast-099_Lung-Video_MMiLC_Panel_Discussion_pt4.m4v
Category:Lung-Cancer-Video -- posted at: 4:51pm PDT

Panel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer patients.

Direct download: GRACEcast-098_Lung-Audio_MMiLC_Panel_Discussion_pt3.mp3
Category:Lung-Cancer-Audio -- posted at: 7:05pm PDT

Panel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer patients.

Direct download: GRACEcast-098_Lung-Video_MMiLC_Panel_Discussion_pt3.m4v
Category:Lung-Cancer-Video -- posted at: 7:04pm PDT

Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology.

Direct download: GRACEcast-097_Lung-Audio_MMiLC_Shaw_on_Patterns_pt2.mp3
Category:Lung-Cancer-Audio -- posted at: 4:04pm PDT

Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology.

Direct download: GRACEcast-097_Lung-Video_MMiLC_Shaw_on_Patterns_pt2.m4v
Category:Lung-Cancer-Video -- posted at: 4:03pm PDT

Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.

Direct download: GRACEcast-096_Lung-Audio_MMiLC_Rudin_on_Consortium_pt1.mp3
Category:Lung-Cancer-Audio -- posted at: 4:58pm PDT

Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.

Direct download: GRACEcast-096_Lung-Video_MMiLC_Rudin_on_Consortium_pt1.m4v
Category:Lung-Cancer-Video -- posted at: 4:55pm PDT

Q and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011.

Direct download: GRACEcast-095_Lung-Audio_2011_Lung_Cancer_Highlights_pt4.mp3
Category:Lung-Cancer-Audio -- posted at: 3:40pm PDT

Q and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011.

Direct download: GRACEcast-095_Lung-Video_2011_Lung_Cancer_Highlights_pt4.m4v
Category:Lung-Cancer-Video -- posted at: 3:39pm PDT

Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, here describing evidence supporting lung cancer screening by chest CT, as well as evidence on how best to treat elderly patients with advanced lung cancer.

Direct download: GRACEcast-094_Lung-Video_2011_Lung_Cancer_Highlights_pt3b.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, here describing evidence supporting lung cancer screening by chest CT, as well as evidence on how best to treat elderly patients with advanced lung cancer.

Direct download: GRACEcast-094_Lung-Audio_2011_Lung_Cancer_Highlights_pt3.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PDT

Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, with this podcast focusing on ALK rearrangements and new molecular targets in lung cancer.

Direct download: GRACEcast-093_Lung-Video_2011_Lung_Cancer_Highlights_pt2.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PDT

Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, with this podcast focusing on ALK rearrangements and new molecular targets in lung cancer.

Direct download: GRACEcast-093_Lung-Audio_2011_Lung_Cancer_Highlights_pt2.mp3
Category:Lung-Cancer-Audio -- posted at: 8:00am PDT

The GRACEcast feeds on iTunes are moving!


The GRACEcast feeds on iTunes are moving!


The GRACEcast feeds on iTunes are moving!

Direct download: GRACEcast-092_Radiation-Audio_GRACEcast_Feeds_Moving.mp3
Category:Radiation-Audio -- posted at: 3:01pm PDT

The GRACEcast feeds on iTunes are moving!

Direct download: GRACEcast-092_Radiation-Video_GRACEcast_Feeds_Moving.m4v
Category:Radiation-Video -- posted at: 3:00pm PDT

The GRACEcast feeds on iTunes are moving!

Direct download: GRACEcast-092_Lung-Cancer-Audio_GRACEcast_Feeds_Moving.mp3
Category:Lung-Cancer-Audio -- posted at: 2:58pm PDT

The GRACEcast feeds on iTunes are moving!

Direct download: GRACEcast-092_Lung-Cancer-Video_GRACEcast_Feeds_Moving.m4v
Category:Lung-Cancer-Video -- posted at: 2:57pm PDT